ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 717553 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 717553; 2) Community: the network communities that were significantly associated with the response to NSC 717553; 3) Molecule: the relationships between components within communities and NSC 717553; 4) MDR: the compounds that were significantly associated with the NSC 717553.

NSC Compound Enrichment Correlation
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0407060322613561 0.37193183
NSC 748404 Null 0.0407060322613561 0.46512944
NSC 748707 Null 0.0407060322613561 0.095132717
NSC 748904 [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine 0.0407060322613561 0.23061329
NSC 1390 Allopurinol 0.0407060322613564 0.12758377
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0407060322613564 0.10297983
NSC 526417 Echinomycin (8CI) 0.0407060322613564 -0.049586498
NSC 645621 Thiourea, N-[4-[(3,4,5-trimethoxyphenyl)methyl]-5-thioxo- 1,2,4-dithiazol-2-ylidene]-N',N'-dimethyl- 0.0407060322613564 0.3886401
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.0407060322613564 0.045477563
NSC 650012 Null 0.0407060322613564 0.12496317
Total:34  Current:27    [First] [Prev] [Next] [Last]